Baxter closed a facility in North Carolina due to extensive flooding caused by Hurricane Helene, the company said on Sunday. A company spokesperson said Monday that there were no injuries at the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Sales of dialysis products from Baxter International’s ...
After almost a year of negotiations, Baxter has reached a $4 billion deal for Swedish firm Gambro AB. The acquisition is part of a larger effort by Baxter to corner the kidney dialysis market. Gambro ...
Baxter’s Sharesource remote patient management platform has logged more than 5 million home peritoneal dialysis treatments globally; milestone is evidence that smarter, more effective innovation is ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, announced today new data indicating the use of Baxter’s Sharesource remote patient management ...
Baxter International (Deerfield, IL) completed its acquisition of Gambro AB, a Swedish dialysis products manufacturer. With the completion of its latest acquisition, the company is in a strong ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Baxter International Inc., one of the biggest makers of ...
DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...
Please provide your email address to receive an email when new articles are posted on . Baxter International Inc. has added a new digital component to its resources for patients on peritoneal dialysis ...
First-of-its-kind curriculum educates peritoneal dialysis (PD) nurses in one easily accessible resource Learners earn continuing education (CE) credits and expand knowledge on PD management best ...
Baxter International says it's achieved a 25% lower mortality risk for up to four years in hemodialysis patients in a study of its new therapy. In a 48-month study of 1,092 dialysis patients, Baxter's ...
Baxter ($BAX) launched a new type of hemodialysis in a handful of countries, which uses a new dialyzer that filters a greater range of molecules from the blood ...